- Home
- INDP vs LUXH Comparison
INDP vs LUXH Comparison
Compare INDP & LUXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INDP
- LUXH
- Stock Information
- Founded
- INDP 2000
- LUXH 2017
- Country
- INDP United States
- LUXH United States
- Employees
- INDP N/A
- LUXH N/A
- Industry
- INDP Biotechnology: Pharmaceutical Preparations
- LUXH Real Estate
- Sector
- INDP Health Care
- LUXH Finance
- Exchange
- INDP Nasdaq
- LUXH Nasdaq
- Market Cap
- INDP 10.2M
- LUXH 1.8M
- IPO Year
- INDP N/A
- LUXH N/A
- Fundamental
- Price
- INDP $0.94
- LUXH $0.99
- Analyst Decision
- INDP Strong Buy
- LUXH Hold
- Analyst Count
- INDP 2
- LUXH 2
- Target Price
- INDP $8.50
- LUXH N/A
- AVG Volume (30 Days)
- INDP 25.8K
- LUXH 1.9M
- Earning Date
- INDP 11-12-2024
- LUXH 11-20-2024
- Dividend Yield
- INDP N/A
- LUXH N/A
- EPS Growth
- INDP N/A
- LUXH N/A
- EPS
- INDP N/A
- LUXH N/A
- Revenue
- INDP N/A
- LUXH $72,790,178.00
- Revenue This Year
- INDP N/A
- LUXH N/A
- Revenue Next Year
- INDP N/A
- LUXH $15.51
- P/E Ratio
- INDP N/A
- LUXH N/A
- Revenue Growth
- INDP N/A
- LUXH N/A
- 52 Week Low
- INDP $0.84
- LUXH $0.53
- 52 Week High
- INDP $3.10
- LUXH $481.60
- Technical
- Relative Strength Index (RSI)
- INDP 40.51
- LUXH 38.65
- Support Level
- INDP $0.94
- LUXH $0.53
- Resistance Level
- INDP $1.01
- LUXH $1.19
- Average True Range (ATR)
- INDP 0.06
- LUXH 0.26
- MACD
- INDP 0.00
- LUXH 0.12
- Stochastic Oscillator
- INDP 28.24
- LUXH 27.81
About INDP Indaptus Therapeutics Inc.
Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's pre-clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.
About LUXH LuxUrban Hotels Inc.
LuxUrban Hotels Inc utilizes a long term lease, asset-light business model to acquire and manage a growing portfolio of short-term rental properties in metropolitan cities. It identifies, acquires, manages, and markets hotel rooms to business and vacation travelers under the consumer brand, LuxUrban. It manages a portfolio of hotel rooms in New York, Washington D.C., Miami Beach, New Orleans and Los Angeles.